New ablation combo may keep AFib at bay longer

NCT ID NCT03057548

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether adding ablation of the left atrial posterior wall to standard pulmonary vein isolation reduces the return of atrial fibrillation in people with persistent AF. A total of 110 adults having their first catheter ablation took part. The goal was to see if the combined procedure leads to fewer arrhythmia episodes one year later.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
catheter ablation procedure
What this could lead to
If successful, this combined ablation approach could offer a more effective way to control persistent atrial fibrillation and reduce the chance of it coming back.
What could go wrong
This is a completed trial with 110 participants, so results are limited in size. The procedure carries risks like bleeding or heart complications, and the added ablation may not provide extra benefit over standard treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION CHRONIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Heart Center, Japan Red Cross Yokohama-city Bay Hospital

    Yokohama, Japan

  • Mercy General Hospital and Dignity Health Heart and Vascular Institute

    Sacramento, California, 95819, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.